Citi Research has lowered its year-end Nifty 50 target to 27,000, citing escalating Middle East war risks impacting India’s growth and corporate earnings. Surging oil and supply shocks are worsening the economic outlook, with potential disruptions to LPG, LNG, fertilizers, and petrochemicals. The brokerage also downgraded the auto sector to ‘neutral’ due to price spikes and potential semiconductor issues.
Aarti Pharmalabs shares rally over 33% in two days post Q1 results. What is driving the surge?
Aarti Pharmalabs shares have surged 33% in two days after the company reported a 65.4% year-on-year rise in Q1FY27 profit and 38.7% growth in revenue.